Management of melanoma recurrence following adjuvant anti-PD1 therapy

被引：0
|
作者：
Owen, C. [1 ]
Palmieri, D. [2 ]
Guminski, A. [3 ,4 ]
Carlino, M. S. [5 ]
Menzies, A. M. [6 ]
Long, G. V. [6 ]
机构：
[1] Melanoma Inst Australia, Melanoma Med Oncol, Sydney, NSW, Australia
[2] Westmead Hosp, Med Oncol, Westmead, NSW, Australia
[3] Univ Sydney, Royal North Shore Hosp, Melanoma Inst Australia, Dept Med Oncol, Sydney, NSW, Australia
[4] Univ Sydney, Mater Hosp, Melanoma Inst Australia, Dept Med Oncol, Sydney, NSW, Australia
[5] Univ Sydney, Melanoma Inst Australia, Crown Princess Mary Canc Ctr, Med Oncol, Westmead, NSW, Australia
[6] Univ Sydney, Melanoma Inst Australia, Med Oncol, Sydney, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1252P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.
    Owen, Carina N.
    Larkin, James M. G.
    Shoushtari, Alexander Noor
    Carlino, Matteo S.
    Blank, Christian U.
    Lee, Belinda
    Mangana, Joanna
    Atkinson, Victoria
    Millward, Michael
    Zaman, Farzana
    Young, Arissa
    Khattak, Muhammad Adnan
    Patel, Sapna Pradyuman
    Hoeller, Christoph
    Hersey, Peter
    Chauhan, Dharmisha
    Palmieri, David James
    Lo, Serigne
    Menzies, Alexander M.
    Long, Georgina V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Metabolic factors affecting response to adjuvant anti-PD1 therapy for melanoma
    Bruno, Sabrina
    Knight, Andrew David
    Wang, Hong
    Sander, Cindy
    Karapetyan, Lilit
    Kirkwood, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
    Owen, C. N.
    Shoushtari, A. N.
    Chauhan, D.
    Palmieri, D. J.
    Lee, B.
    Rohaan, M. W.
    Mangana, J.
    Atkinson, V
    Zaman, F.
    Young, A.
    Hoeller, C.
    Hersey, P.
    Dummer, R.
    Khattak, M. A.
    Millward, M.
    Patel, S. P.
    Haydon, A.
    Johnson, D. B.
    Lo, S.
    Blank, C. U.
    Sandhu, S.
    Carlino, M. S.
    Larkin, J. M. G.
    Menzies, A. M.
    Long, G., V
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (08) : 1075 - 1082
  • [4] Nature and management of melanoma recurrences following adjuvant anti-PD-1 (PD1) therapy
    Woodford, Rachel
    McKeown, Janet
    Hoeijmakers, Lotte
    Mangana, Joanna
    Lebbe, Celeste
    Zaman, Farzana Yasmin
    Aya, Francisco
    Marsiglio, John
    Goodman, Rachel S.
    Rayson, Victoria
    Placzke, Joanna
    Kessels, Jolien Isabel
    Ramelyte, Egle
    Haque, Waqas
    Wilson, Isabella
    Trojaniello, Claudia
    Roberts-Thomson, Rachel
    Robert, Caroline
    Long, Georgina V.
    Menzies, Alexander M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
    Woodford, Rachel
    McKeown, Janet
    Hoeijmakers, Lotte L.
    Mangana, Johanna
    Dimitriou, Florentia
    Allayous, Clara
    Zaman, Farzana
    Aya, Francisco
    Marsiglio, John
    Goodman, Rachel
    Rayson, Victoria
    Placzke, Joanna
    Kessels, Jolien
    Ramalyte, Egle
    Haque, Waqas
    Wilson, Isabella
    Trojaniello, Claudia
    Benannoune, Naima
    Roberts-Thomson, Rachel
    Robert, Caroline
    Blank, Christian U.
    Dummer, Reinhard
    Lebbe, Celeste
    Haydon, Andrew
    Arance, Ana
    Hu-Lieskovan, Siwen
    Johnson, Douglas B.
    Mcarthur, Grant A.
    Rutkowski, Piotr
    Neyns, Bart
    Sullivan, Ryan J.
    Weber, Jeffrey
    Carlino, Matteo S.
    Ascierto, Paolo A.
    Lo, Serigne
    Long, Georgina, V
    Menzies, Alexander M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [6] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [7] How anti-PD1 treatments are changing the management of melanoma
    Hersey, Peter
    Kakavand, Hojabr
    Wilmott, James
    van der Westhuizen, Andre
    Gallagher, Stuart
    Gowrishankar, Kavitha
    Scolyer, Richard
    [J]. MELANOMA MANAGEMENT, 2014, 1 (02) : 165 - 172
  • [8] Anti-PD1 antibodies in the adjuvant setting
    Dreno, B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 14 - 14
  • [9] Clinical outcomes after adjuvant anti-PD1 therapy for high-risk resectable melanoma and predictors of response
    Marsiglio, John
    Bingjian, Feng
    Kovacsovics, Magdalena
    Gibson, Berit
    Zhou, Qin
    Swami, Umang
    Russell, Jeffery Scott
    Erickson-Wayman, Alyssa
    Asare, Elliot Amponsah
    Monroe, Marcus
    Bowles, Tawnya Lynn
    Nix, David
    Williams, Matthew
    Tan, Aik-choon
    Hyngstrom, John Robert
    Hu-Lieskovan, Siwen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy
    Doonan, Bently Patrick
    Shaw, Christiana M.
    Lee, Ji-Hyun
    Manso, Eugenio Simon
    Mendez-Gomez, Hector
    Von Roemeling, Christina
    Mitchell, Duane Anthony
    Sayour, Elias
    George, Thomas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345